a Randomized Clinical Trial Evaluating the Effectiveness of Carbon Dioxide Use in Cardiac Surgery (NCT04548687) | Clinical Trial Compass
UnknownNot Applicable
a Randomized Clinical Trial Evaluating the Effectiveness of Carbon Dioxide Use in Cardiac Surgery
Russia120 participantsStarted 2020-06-19
Plain-language summary
study of the efficacy and safety of carbon dioxide in cardiac surgery: repeated or minimally invasive
Who can participate
Age range18 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Planned cardiac surgery on the left heart with limited deaeration: Minimally invasive approach (mininotomy, minimally invasive lateral thoracotomy); Re-intervention
* Signed informed voluntary consent
Exclusion Criteria:
* Patient refusal to participate in any stage of the study
* History of stroke, transient ischemic attack
* Hemodynamically significant stenosis of the brachiocephalic arteries (more than 70%)
* Swelling or thrombosis of the heart
* LV dysfunction (EF less than 30%)
* Atherosclerosis of the aorta (atheromatosis)
* Surgical access conversion
What they're measuring
1
delirium: CAM-ICU, 3-D CAM
Timeframe: 7 days after surgery
Trial details
NCT IDNCT04548687
SponsorMeshalkin Research Institute of Pathology of Circulation